Rhinosinusitis derived Staphylococcal enterotoxin B possibly associates with pathogenesis of ulcerative colitis

BMC Gastroenterology

Volumn 5, Issue , 2005, Pages

  Yang, Ping Chang ^a,b   Liu, Tao ^b   Wang, Bin Quan ^b   Zhang, Tao Yuan ^b   An, Zi Yuan ^b   Zheng, Peng Yuan ^c   Tian, Dao Fa ^d  

^a MCMASTER UNIVERSITY   (Canada)

^b SHANXI MEDICAL UNIVERSITY   (China)

^c ZHENGZHOU UNIVERSITY   (China)

^d HUNAN UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; CORTICOSTEROID; HISTAMINE; IMMUNOGLOBULIN E ANTIBODY; PENICILLIN G; PREDNISOLONE; SALAZOSULFAPYRIDINE; STAPHYLOCOCCUS ENTEROTOXIN B; TRYPTASE; ENTEROTOXIN; ENTEROTOXIN B, STAPHYLOCOCCAL; SERINE PROTEINASE;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; BACTERIAL COUNT; BACTERIAL GROWTH; BACTERIUM COLONY; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CELL ACTIVATION; COLON BIOPSY; COLON MUCOSA; CONTROLLED STUDY; DISEASE ASSOCIATION; ELECTRON MICROSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; FEMALE; HISTAMINE RELEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MAST CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; RHINOSINUSITIS; SCORING SYSTEM; STAPHYLOCOCCUS AUREUS; SURGICAL INFECTION; SYMPTOM; ULCERATIVE COLITIS; CASE CONTROL STUDY; CHRONIC DISEASE; ENDOSCOPY; IMMUNOLOGY; ISOLATION AND PURIFICATION; LAVAGE; METABOLISM; MICROBIOLOGY; MIDDLE AGED; PARANASAL SINUS; RESPIRATORY TRACT MUCOSA; RHINITIS; SINUSITIS;

ADULT; AGED; ANTIBODIES, BACTERIAL; CASE-CONTROL STUDIES; CHRONIC DISEASE; COLITIS, ULCERATIVE; ENDOSCOPY; ENTEROTOXINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTAMINE RELEASE; HUMANS; MALE; MIDDLE AGED; PARANASAL SINUSES; RESPIRATORY MUCOSA; RHINITIS; SERINE ENDOPEPTIDASES; SINUSITIS; STAPHYLOCOCCUS AUREUS; THERAPEUTIC IRRIGATION; TRYPTASES;

EID: 26444503730     PISSN: 1471230X     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-5-28     Document Type: Article

References (56)

1. Macdonald TT, Monteleone G, Pender SLF: Recent developments in the immunology of inflammatory bowel disease. Scand J Immunol 2000, 51:2-9.
2. Campieri M, Gionchetti P: Bacteria as the cause of ulcerative colitis. Gut 2001, 48:132-5.
3. Kanai T, Watanabe M: Clinical application of human CD4+ CD25+ regulatory T cells for the treatment of inflammatory bowel diseases. Expert Opin Biol Ther 2005, 5:451-62.
4. Annese V, Latiano A, Rossi L, Lombardi G, Dallapiccola B, Serafini S, Damonte G, Andriulli A, Magnani M: Erythrocytes-Mediated Delivery of Dexamethasone in Steroid-Dependent IBD Patients-A Pilot Uncontrolled Study. Am J Gastroentero 2005, 100:1370-5.
5. Su C, Lichtenstein GR: Recent developments in inflammatory bowel disease. Med Clin North Am 2002, 86:1497-523.
6. Cima RR, Pemberton JH: Medical and surgical management of chronic ulcerative colitis. Arch Surg 2005, 140:300-10.
7. Campieri M: New steroids and new salicylates in inflammatory bowel disease: a critical appraisal. Gut 2002, 50(Suppl 3):11143-6.
8. Baert FJ, Rutgeerts PJ: Medical therapies for ulcerative colitis and crohn's disease. Curr Gastroenterol Rep 2000, 2:446-450.
9. McKay DM: Intestinal inflammation and the gut microflora. Can J Gastroenterol 1999, 13:509-516.
10. Benjamin MA, Lu J, Donnely G, Dureja P, McKay DM: Changes in murine jejunal morphology evoked by the bacterial superantigen Staphylococcus aureus enterotoxin B are mediated by CD4+ T cells. Infect Immun 1998, 66:2193-9.
11. Zhou P, Borojevic R, Streutker C, Terry NG, Croitoru K: Oral Administration Of Bacterial Superantigen Activates a Severe Colitis in the Absence Of Regulatory T Cells. Gastroenterology 2005, 128(Suppl 2):170.
12. Hamad AR, Marrack P, Kappler JW: Transcytosis of staphylococcal superantigen toxins. J Exp Med 1997, 185:1447-54.
13. Roberts AI, Blumberg RS, Christ AD, Brolin RE, Ebert EC: Staphylococcal enterotoxin B induces potent cytotoxic activity by intraepithelial lymphocytes. Immunology 2000, 101:185-90.
14. Cong Y, Brandwein SL, McCabe RP, Lazenby A, Birkenmeier EH, Sundberg JP, Elson CO: CD4+ T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/HeJBir mice: increased T helper cell type 1 response and ability to transfer disease. J Exp Med 1998, 187:855-64.
15. Siebrecht MS, Hsia E, Spychalski C, Nagler-Anderson C: Stimulation of murine intestinal intraepithelial lymphocytes by the bacterial superantigen staphylococcal enterotoxin B. Int Immunol 1993, 5:717-24.
16. Spiekermann GM, Nagler-Anderson C: Oral administration of the bacterial superantigen staphylococcal enterotoxin B induces activation and cytokine production by T cells in murine gut-associated lymphoid tissue. J Immunol 1998, 161:5825-31.
17. Dionne S, Laberge S, Deslandres C, Seidman EG: Modulation of cytokine release from colonic explants by bacterial antigens in inflammatory bowel disease. Clin Exp Immunol 2003, 133:108-14.
18. Baker MD, Acharya KR: Superantigens: structure-function relationships. Int J Med Microbiol 2004, 293:529-37.
19. Lu J, Wang A, Ansari S, Hershberg RM, McKay DM: Colonic bacterial superantigens evoke an inflammatory response and exaggerate disease in mice recovering from colitis. Gastroenterology 2003, 125:1785-95.
20. Lu J, Philpott DJ, Saunders PR, Perdue MH, Yang PC, McKay DM: Epithelial ion transport and barrier abnormalities evoked by superantigen-activated immune cells are inhibited by interleukin-10 but not interleukin-4. J Pharmacol Exp Ther 1998, 287:128-36.
21. Yang PC, Wang CS, An ZY: A murine model of ulcerative colitis: induced with sinusitis-derived superantigen and food allergen. BMC Gastroenterol 2005, 5:6.
22. Bernstein JM, Kansal R: Superantigen hypothesis for the early development of chronic hyperplastic sinusitis with massive nasal polyposis. Curr Opin Otolaryngol Head Neck Surg 2005, 13:39-44.
23. Conley DB, Tripathi A, Ditto AM, Reid K, Grammer LC, Kern RC: Chronic sinusitis with nasal polyps: staphylococcal exotoxin immunoglobulin E and cellular inflammation. Am J Rhinol 2004, 18:273-8.
24. McKay DM: Bacterial superantigens: provocateurs of gut dysfunction and inflammation. Trends Immunol 2001, 22:497-501.
25. Ibbotson JP, Lowes JR: Potential role of superantigen induced activation of cell mediated immune mechanisms in the pathogenesis of Crohn's disease. Gut 1995, 36:1-4.
26. Kluytmans JA, Wertheim HF: Nasal carriage of Staphylococcus aureus and prevention of nosocomial infections. Infection 2005, 33:3-8.
27. Okano M, Hattori H, Yoshino T, Sugata Y, Yamamoto M, Fujiwara T, Satoskar AA, Satoskar AR, Nishizaki K: Nasal exposure to Staphylococcal enterotoxin enhances the development of allergic rhinitis in mice. Clin Exp Allergy 2005, 35:506-14.
28. Rossi RE, Monasterolo G: Prevalence of serum IgE antibodies to the Staphylococcus aureus enterotoxins (SAE, SEB, SEC, SED, TSST-1) in patients with persistent allergic rhinitis. Int Arch Allergy Immunol 2004, 133:261-6.
29. Ashraf N, Bhattacharyya N: Determination of the "incidental" Lund score for the staging of chronic rhinosinusitis. Otolaryngol Head Neck Surg 2001, 125:483-6.
30. Regueiro MD: Diagnosis and treatment of ulcerative proctitis. J Clin Gastroenterol 2004, 38:733-40.
31. Schroeder KW, Tremaine WJ, Ilstrup DM: Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med 1987, 317:1625-9.
32. Frisch T, Arndal H, Fons M: Outcome for the first 85 patients treated with the functional endoscopic sinus surgery technique. Rhinology 1995, 33:236-9.
33. Latkovskis G, Licis N, Kalnins U: C-reactive protein levels and common polymorphisms of the interleukin-1 gene cluster and interleukin-6 gene in patients with coronary heart disease. Eur J Immunogenet 2004, 31:207-13.
34. Okano M, Takishita T, Yamamoto T, Hattori H, Yamashita Y, Nishioka S, Ogawa T, Nishizaki K: Presence and characterization of sensitization to staphylococcal enterotoxins in patients with allergic rhinitis. Am J Rhinol 2001, 15:417-21.
35. Riffon R, Sayasith K, Khalil H, Dubreuil P, Drolet M, Lagace J: Development of a rapid and sensitive test for identification of major pathogens in bovine mastitis by PCR. J Clin Microbiol 2001, 39:2584-9.
36. Crivellato E, Nico B, Mallardi F, Beltrami CA, Ribatti D: Piecemeal degranulation as a general secretory mechanism. Anat Rec A Discov Mol Cell Evol Biol 2003, 274:778-84.
37. Book DT, Smith TL, McNamar JP, Saeian K, Binion DG, Toohill RJ: Chronic sinonasal disease in patients with inflammatory bowel disease. Am J Rhinol 2003, 17:87-90.
38. Busaba NY, Siegel N, Salman SD: Bacteriology of nontraumatic maxillary sinus mucoceles versus chronic sinusitis. Laryngoscope 2000, 110:969-71.
39. Gelfand EW: Inflammatory mediators in allergic rhinitis. J Allergy Clin Immunol 2004, 114(5 Suppl):S135-8.
40. Kozel MM, Sabroe RA: Chronic urticaria: aetiology, management and current and future treatment options. Drugs 2004, 64:2515-36.
41. Wilson NW, Self TW, Hamburger RN: Severe cow's milk induced colitis in an exclusively breast-fed neonate. Case report and clinical review of cow's milk allergy. Clin Pediatr (Phila) 1990, 29:77-80.
42. Heine RG: Pathophysiology, diagnosis and treatment of food protein-induced gastrointestinal diseases. Curr Opin Allergy Clin Immunol 2004, 4:221-9.
43. Tohno M, Shimosato T, Kitazawa H, Katoh S, Iliev ID, Kimura T, Kawai Y, Watanabe K, Aso H, Yamaguchi T, Saito T: Toll-like receptor 2 is expressed on the intestinal M cells in swine. Biochem Biophys Res Commun 2005, 330:547-54.
44. Torres BA, Perrin GQ, Mujtaba MG, Subramaniam PS, Anderson AK, Johnson HM: Superantigen enhancement of specific immunity: antibody production and signaling pathways. J Immunol 2002, 169:2907-14.
45. Fan H, Zingarelli B, Peck OM, Teti G, Tempel GE, Halushka PV, Cook JA: Lipopolysaccharide and gram-positive bacteria induced cellular inflammatory responses: Role of heterotrimeric Gαi Proteins. Am J Physiol Cell Physiol 2005, 289:c293-301.
46. McKay DM, Singh PK: Superantigen activation of immune cells evokes epithelial (T84) transport and barrier abnormalities via IFN-gamma and TNF alpha: inhibition of increased permeability, but not diminished secretory responses by TGF-beta2. J Immunol 1997, 159:2382-90.
47. Beaven SW, Abreu MT: Biomarkers in inflammatory bowel disease. Curr Opin Gastroenterol 2004, 20:318-27.
48. Bjerrum L, Gahrn-Hansen B, Munck AP: C-reactive protein measurement in general practice may lead to lower antibiotic prescribing for sinusitis. Br J Gen Pract 2004, 54:659-62.
49. He SH: Key role of mast cells and their major secretory products in inflammatory bowel disease. World J Gastroenterol 2004, 10:309-18.
50. Stoyanova II, Gulubova MV: Mast cells and inflammatory mediators in chronic ulcerative colitis. Acta Histochem 2002, 104:185-92.
51. Crivellato E, Ribatti D: Involvement of mast cells in angiogenesis and chronic inflammation. Curr Drug Targets Inflamm Allergy 2005, 4:9-11.
52. Crivellato E, Finato N, Isola M, Ribatti D, Beltrami CA: Low mast cell density in the human duodenal mucosa from chronic inflammatory duodenal bowel disorders is associated with defective villous architecture. Eur J Clin Invest 2003, 33:601-10.
53. Coelho AM, Ossovskaya V, Bunnett NW: Proteinase-activated receptor-2: physiological and pathophysiological roles. Curr Med Chem Cardiovasc Hematol Agents 2003, 1:61-72.
54. Schreiber S, Raedler A, Stenson WF, MacDermott RP: The role of the mucosal immune system in inflammatory bowel disease. Gastroenterol Clin North Am 1992, 21:451-502.
55. Kunzelmann K, Schreiber R, Konig J, Mall M: Ion transport induced by proteinase-activated receptors (PAR2) in colon and airways. Cell Biochem Biophys 2002, 36:209-14.
56. Kim JA, Choi SC, Yun KJ, Kim DK, Han MK, Seo GS, Yeom JJ, Kim TH, Nah YH, Lee YM: Expression of protease-activated receptor 2 in ulcerative colitis. Inflamm Bowel Dis 2003, 9:224-9.